HeyJaredKathy Vuksanaj
- Indexed articles, last 90 days
- 9
- Latest publication
- Aug 1, 2026
- Outlet visibility, for Inside Precision Medicine
- Top 1M sites
- Earliest in this view
- Aug 1, 2026
Latest articles
Gene-Edited CAR T Expands Rare Disease Horizons (opens the original)
Read excerpt
Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders. The post Gene-Edited CAR T Expands Rare Disease Horizons appeared first on Inside Precision Medicine.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible (opens the original)
Read excerpt
Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon if challenges around funding and reimbursement can be addressed. The post From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible appeared first on Inside Precision Medicine.
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments (opens the original)
Read excerpt
The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial incentives remain limited. This renewed interest has extended well beyond infectious disease, with a major emphasis on rare diseases. The post Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments appeared first on Inside Precision Medicine.
Choice, Flexibility, Access: Can Decentralization Transform Rare Disease Research? (opens the original)
Read excerpt
Precision medicine needs to apply to the clinical trial methodologies as well. Above all, it means designing trials that give patients a realistic pathway for participation. The post Choice, Flexibility, Access: Can Decentralization Transform Rare Disease Research? appeared first on Inside Precision Medicine.
Medicine’s New Frontier Isn’t Sequencing—It’s Sensing in Real Time (opens the original)
Read excerpt
As DNA reading reaches terminal velocity, precision clinical diagnostics are re-routing to directly capture molecular signals like proteins, metabolites, and other biomolecules. The post Medicine’s New Frontier Isn’t Sequencing—It’s Sensing in Real Time appeared first on Inside Precision Medicine.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For Inside Precision Medicine, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.